Literature DB >> 8070934

Mucocutaneous diseases in drug addicts with or without HIV infection. A case-control study.

G B Gaeta1, A Maisto, C Sichenze, R A Satriano, C Sardaro, G Giusti.   

Abstract

A case-control study was performed to evaluate the prevalence of mucocutaneous diseases in 106 male drug addicts (age 21-38 years) with or without HIV infection. A mucocutaneous disease was recorded in ten out of 64 HIV-negative and in 20 of 42 HIV-positive patients (OR = 4.9; p < 0.01). Some mucocutaneous diseases were present in similar proportions in both groups (i.e. fungal skin lesions), while others were typically present only in HIV-positive patients. Stratification for possible confounding factors, such as years of drug addiction and number of sexual partners, confirmed that HIV infection is the main risk factor for mucocutaneous disease. Stratification according to the number of CD4-positive cells showed that the more advanced the HIV disease, the more frequently mucocutaneous disease was present (p = 0.02). The study demonstrates that many, but not all, mucocutaneous diseases are associated with HIV infection.

Entities:  

Mesh:

Year:  1994        PMID: 8070934     DOI: 10.1007/bf01739008

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients.

Authors:  J J Schwartz; P L Myskowski
Journal:  J Am Acad Dermatol       Date:  1992-10       Impact factor: 11.527

Review 2.  Fungal infections in patients with AIDS and AIDS-related complex.

Authors:  K Holmberg; R D Meyer
Journal:  Scand J Infect Dis       Date:  1986

3.  Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.

Authors:  R S Klein; C A Harris; C B Small; B Moll; M Lesser; G H Friedland
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

4.  The spectrum of nail disease in patients with human immunodeficiency virus infection.

Authors:  C R Daniel; L A Norton; R K Scher
Journal:  J Am Acad Dermatol       Date:  1992-07       Impact factor: 11.527

5.  Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals.

Authors:  A E Friedman-Kien; F L Lafleur; E Gendler; N P Hennessey; R Montagna; S Halbert; P Rubinstein; K Krasinski; E Zang; B Poiesz
Journal:  J Am Acad Dermatol       Date:  1986-06       Impact factor: 11.527

6.  Clinical features of inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter Reed stage. Military Medical Consortium for Applied Retroviral Research.

Authors:  K J Smith; H G Skelton; J Yeager; D Baxter; P Angritt; S Johnson; C N Oster; K F Wagner
Journal:  J Am Acad Dermatol       Date:  1993-02       Impact factor: 11.527

7.  Seborrheic dermatitis in patients with acquired immunodeficiency syndrome.

Authors:  B M Mathes; M C Douglass
Journal:  J Am Acad Dermatol       Date:  1985-12       Impact factor: 11.527

8.  Herpes zoster and human immunodeficiency virus infection.

Authors:  S P Buchbinder; M H Katz; N A Hessol; J Y Liu; P M O'Malley; R Underwood; S D Holmberg
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

9.  Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS).

Authors:  M H Kaplan; N Sadick; N S McNutt; M Meltzer; M G Sarngadharan; S Pahwa
Journal:  J Am Acad Dermatol       Date:  1987-03       Impact factor: 11.527

10.  Skin disease in homosexual patients with acquired immune deficiency syndrome (AIDS) and lesser forms of human T cell leukaemia virus (HTLV III) disease.

Authors:  C F Farthing; R C Staughton; C M Rowland Payne
Journal:  Clin Exp Dermatol       Date:  1985-01       Impact factor: 3.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.